Drug middlemen inflate US prices, squeeze out competition, FTC says
Ars Technica » Scientific Method 2024-07-09
Summary:
Pharmacy benefit managers (PBMs) are key part of US's high drug costs, report finds.
Link:
https://arstechnica.com/?p=2036032From feeds:
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific MethodCyberlaw » Ars Technica
Music and Digital Media » Ars Technica